CryoLife Inc. (NYSE:CRY) announced that it had its investigational new drug application accepted by the FDA for a clinical trial to observe whether the On-X mechanical aortic valve can be maintained on apixaban instead of warfarin. The On-X aortic valve is the first mechanical aortic heart valve to win FDA and CE Mark approval for labeling […]
CryoLife, Misonix sign distribution deal for NeoPatch
CryoLife this week said it signed a distribution agreement with Misonix where Misonix will have exclusive commercialization rights of NeoPatch. The NeoPatch, made by CryoLife, is a dehydrated and terminally sterilized chorioamniotic allograft that is made from human placental membrane. It is designed to treat a wide range of indications outside of cardiac and vascular […]
CryoLife wins CE Mark for E-nya thoracic stent graft
CryoLife Inc. (NYSE:CRY) announced that it received CE Mark approval for its E-nya thoracic stent graft system for minimally invasive procedures intended to repair lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections. In December 2017, CryoLife completed the $225 million acquisition of German stent graft and surgical graft maker Jotec. Kennesaw, Ga.-based […]
CryoLife, EndoSpan ink distribution deal
CryoLife Inc. (NYSE:CRY) today announced that it has signed a strategic distribution and credit facility agreement with Endospan with an option to purchase the company. Kennesaw, Georgia-based CryoLife will have exclusive distribution rights to Endospan’s Nexus stent graft system in Europe. CryoLife will pay $10 million upfront and provide up to $15 million in debt financing […]
CryoLife gains on Street-beating Q1 sales, confirmed outlook
CryoLife Inc. (NYSE:CRY) shares got a jump today after the medical device maker slashed its losses, beat the consensus sales forecast and confirmed its outlook on the rest of the year. Atlanta-based CryoLife reported losses of -$297,000, or -1¢ per share, on sales of $67.5 million for the three months ended March 31, reducing its […]
10 of the best performing medical device stocks of 2018
Updated Jan. 8, 2019 Medical device company stocks are not looking as rosy as they did two months ago, but the medtech industry still appears to be resisting the overall downward trend in stock markets, according to a Medical Design & Outsourcinganalysis. More than half of the roughly 100 largest medical device companies in the world […]
CryoLife’s Q3 sales, earnings miss forecast
CryoLife Inc. (NYSE:CRY) shares are down today after the medical device maker yesterday reported third-quarter results that missed expectations. The Atlanta-area company posted profits of $1.6 million, or 4¢ per share, on sales of $64.6 million for the three months ended Sept. 30, for a bottom-line gain of 18.1% on sales growth of 46.8% compared […]
CryoLife gains on Q3 prelim beat
CryoLife Inc. (NYSE:CRY) shares ticked up today after it announced preliminary third-quarter sales numbers that beat the consensus forecast on Wall Street. Kennesaw, Ga.-based CryoLife said it expects to post sales of roughly $64.6 million, 4.5% ahead of The Street’s forecast for a $61.8 million top line. “Our third-quarter revenue results were driven by continuing […]
Boston Children’s, Boston Pediatric Device Consortium announces device challenge winners
The Boston Pediatric Device Strategic Partner Challenge recently announced its winners, including cardiovascular devices that expand to keep pace with growing child, a nitric oxide generator, a cardiovascular diagnostic device and other novel pediatric devices. The challenge, run by the Innovation and Digital Health Accelerator at Boston Children’s Hospital and the Boston Pediatric Device Consortium, […]
CryoLife closes $225m acquisition of German graft maker Jotec
CryoLife Inc. (NYSE:CRY) said last Friday it completed its previously announced $225 million acquisition of German stent graft and surgical graft maker Jotec In the deal, Cryolife paid $168.8 million in cash and the remaining $56.26 million in shares of Cryolife. The acquisition was funded through the combination of a $225 million term loan and $30 million […]
CryoLife inks $225m deal for German graft maker Jotec
CryoLife Inc. (NYSE:CRY) said yesterday that it agreed to a cash-and-stock deal worth $225 million to acquire German stent graft and surgical graft maker Jotec. The deal calls for Cryolife to pay $168.8 million in cash and the remaining $56.25 million in CRY shares, financed by a $225 million term loan and a $30 million […]
- 1
- 2
- 3
- …
- 5
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube